SHANGHAI, Feb. 27, 2013 /CNW/ - Organized by CPhI Conferences, Quality by Design China 2013 will take place on 17-18 April in Shanghai. The organizer has announced that more than 15 professional people have been invited to be speakers, including Mr. Ning Baoming, Deputy Director from the National Institute for Food and Drug Control (NIFDC); Mr. Gu Ziqiang, Former US FDA CMC reviewer and GMP Compliance from the FDA; Mr. Chen Binhua, General Manager from Shanghai No. 1 Biochemical & Pharmaceutical; Chen Yisheng, Vice President from Novast Laboratories, and Mojgan Moshgbar, Director from Pfizer. They will bring you hot industry topics such as QbD implementation in China and the specific standard; Utilizing FDA regulation with QbD to get through the evaluation process; QbD application in pharmaceutical stability of production process; ANDA regulations and QbD in pharmaceutical development, and some fabulous case studies as well.
Meanwhile, the organizer has shared with you with some excellent presentations about QbD Implementation:
1. "QbD and PAT: From Science to Compliance"
[Author] Pedro E. Hernandez-Abad, Associate Director, Wyeth
Jun Huang,Principal PAT Scientist II, Wyeth
Saly Romero-Torres,Principal PAT Scientist, Wyeth
2. "A QbD Implementation Roadmap for the Generics Industry"
[Author] Bikash Chatterjee, Pharmatech Associates
3. "Practical Application of QbD for a Parentral Drug Product"
[Author] Nancy J. Harper, Venkat Koganti and Gautam R. Ranade,Pfizer
4. "Define,Design and Develop Analytical Methods"
[Author] Fred Xi, Ph.D
Please click on the link to download the presentations: http://www.qbd-china.com/Download.aspx?id=6&lang=en-us
Ms. Tracy Cui
Tel: +86-21-6157 3919
Fax: +86-21-6157 7299
SOURCE: CPhI Conferences
For further information: